Expression and Correlation of MIF and ERK1/2 in Liver Cirrhosis and Hepatocellular Carcinoma Induced by Hepatitis B

References

• Yu XH, Zhang FX, Sun YB, et al. 巨噬细胞移动抑制因子在乙型肝炎肝硬化形成中的可能作用 [Possible role of macrophage mobility inhibitory factor in the formation of hepatitis B cirrhosis]. Chin J Dig. 2007;27(04):270–272. Chinese.
   Google Scholar
• Yu XH. MIF在HBV感染相关性肝病中的表达及其可能机制研究 [Expression of MIF in HBV Infection-Associated Liver Disease and Its Possible Mechanism]. SCU (Sichuan University; 2005. Chinese.
   Google Scholar
• Ives A, Le Roy D, Theroude C, et al. Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway. FASEB J. 2021;35(5):e21418. doi:10.1096/fj.202001605R
   PubMed Web of Science ®Google Scholar
• Song H, Zhu Z, Zhou Y, et al. MIF/CD74 axis participates in inflammatory activation of Schwann cells following sciatic nerve injury. J Mol Histol. 2019;50(4):355–367. doi:10.1007/s10735-019-09832-0
   PubMed Web of Science ®Google Scholar
• Jager B, Klatt D, Plappert L, et al. CXCR4/MIF axis amplifies tumor growth and epithelial-mesenchymal interaction in non-small cell lung cancer. Cell Signal. 2020;73:109672. doi:10.1016/j.cellsig.2020.109672
   PubMed Web of Science ®Google Scholar
• H WT, Saal A, Bergmann I, et al. Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma. Br J Pharmacol. 2021;178(22):4452–4467. doi:10.1111/bph.15622
   PubMed Web of Science ®Google Scholar
• Lee H, Kim WJ, Kang HG, et al. Upregulation of LAMB1 via ERK/c-Jun axis promotes gastric cancer growth and motility. Int J Mol Sci. 2021;22(2):626.
   PubMed Web of Science ®Google Scholar
• Savoia P, Fava P, Casoni F, et al. Targeting the ERK signaling pathway in melanoma. Int J Mol Sci. 2019;20(6):1483. doi:10.3390/ijms20061483
   PubMed Web of Science ®Google Scholar
• Zaparte A, Cappellari AR, Brandao CA, et al. P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway. Eur J Pharmacol. 2021;891:173687. doi:10.1016/j.ejphar.2020.173687
   PubMed Web of Science ®Google Scholar
• Urosevic J, Blasco MT, Llorente A, et al. ERK1/2 signaling induces upregulation of ANGPT2 and CXCR4 to mediate liver metastasis in colon cancer. Cancer Res. 2020;80(21):4668–4680. doi:10.1158/0008-5472.CAN-19-4028
   PubMed Web of Science ®Google Scholar
• Xing Y, Liu Y, Qi Z, et al. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway. Cell Mol Biol Lett. 2021;26(1):49. doi:10.1186/s11658-021-00295-4
   PubMed Web of Science ®Google Scholar
• Min J, Hu J, Luo C, et al. IFITM3 upregulates c-myc expression to promote hepatocellular carcinoma proliferation via the ERK1/2 signalling pathway. Biosci Trends. 2020;13(6):523–529. doi:10.5582/bst.2019.01289
   PubMed Web of Science ®Google Scholar
• 中华人民共和国国家卫生健康委员会医政医管局 [Bureau of Medical Administration, National Health Commission of the People's Republic of China]. 原发性肝癌诊疗指南(2022年版) [Guidelines for the diagnosis and treatment of primary liver cancer (2022 edition)]. Chin J Pract Surg. 2022;42(03):241–273. Chinese.
   Google Scholar
• Chen Y, Tian Z. HBV-induced immune imbalance in the development of HCC. Front Immunol. 2019;10:2048. doi:10.3389/fimmu.2019.02048
   PubMed Web of Science ®Google Scholar
• Li L, Li Y, Huang Y, et al. Long non-coding RNA MIF-AS1 promotes gastric cancer cell proliferation and reduces apoptosis to upregulate NDUFA4. Cancer Sci. 2018;109(12):3714–3725. doi:10.1111/cas.13801
   PubMed Web of Science ®Google Scholar
• Song S, Xiao Z, Dekker FJ, et al. Macrophage migration inhibitory factor family proteins are multitasking cytokines in tissue injury. Cell Mol Life Sci. 2022;79:105. doi:10.1007/s00018-021-04038-8
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen Y, Wang C, et al. MIF is a 3’ flap nuclease that facilitates DNA replication and promotes tumor growth. Nat Commun. 2021;12(1):2954. doi:10.1038/s41467-021-23264-z
   PubMed Web of Science ®Google Scholar
• Bozza MT, Lintomen L, Kitoko JZ, et al. The role of MIF on eosinophil biology and eosinophilic inflammation. Clin Rev Allergy Immunol. 2020;58:15–24. doi:10.1007/s12016-019-08726-z
   PubMed Web of Science ®Google Scholar
• Caltabiano R, De Pasquale R, Piombino E, et al. Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) inversely correlate with inflammation in discoid lupus erythematosus. Molecules. 2021;26(1):184. doi:10.3390/molecules26010184
   PubMed Web of Science ®Google Scholar
• Gunther S, Fagone P, Jalce G, et al. Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets. Drug Discov Today. 2019;24(2):428–439. doi:10.1016/j.drudis.2018.11.003
   PubMed Web of Science ®Google Scholar
• Avalos-Navarro G, Munoz-Valle JF, Daneri-Navarro A, et al. Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profile. Clin Exp Med. 2019;19(3):385–391. doi:10.1007/s10238-019-00559-6
   PubMed Web of Science ®Google Scholar
• Zhang H, Duan J, Wu O. The expression of macrophage migration inhibitory factor in the non-small cell lung cancer. Saudi J Biol Sci. 2020;27(6):1527–1532. doi:10.1016/j.sjbs.2020.04.027
   PubMed Web of Science ®Google Scholar
• Qin L, Qin J, Lv X, et al. MIF promoter polymorphism increases peripheral blood expression levels, contributing to increased susceptibility and poor prognosis in hepatocellular carcinoma. Oncol Lett. 2021;22(1):549. doi:10.3892/ol.2021.12810
   PubMed Web of Science ®Google Scholar
• Pacheco-Fernandez T, Juarez-Avelar I, Illescas O, et al. Macrophage migration inhibitory factor promotes the interaction between the tumor, macrophages, and T cells to regulate the progression of chemically induced colitis-associated colorectal cancer. Mediators Inflamm. 2019;2019:2056085. doi:10.1155/2019/2056085
   PubMed Web of Science ®Google Scholar
• Zhang K, Pan X, Shu X, et al. Relationship between MIF-173 G/C polymorphism and susceptibility to chronic hepatitis B and HBV-induced liver cirrhosis. Cell Immunol. 2013;282(2):113–116. doi:10.1016/j.cellimm.2013.04.013
   PubMed Web of Science ®Google Scholar
• Wirtz TH, Reuken PA, Jansen C, et al. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis. JHEP Rep. 2021;3(2):100221. doi:10.1016/j.jhepr.2020.100221
   PubMedGoogle Scholar
• Jeng KS, Lu SJ, Wang CH, et al. Liver fibrosis and inflammation under the control of ERK2. Int J Mol Sci. 2020;21(11):3796. doi:10.3390/ijms21113796
   PubMed Web of Science ®Google Scholar
• Zhang C, Xiao C, Ren G, et al. C-terminal-truncated hepatitis B virus X protein promotes hepatocarcinogenesis by activating the MAPK pathway. Microb Pathog. 2021;159:105136. doi:10.1016/j.micpath.2021.105136
   PubMed Web of Science ®Google Scholar
• Feng PC, Ke XF, Kuang HL, et al. BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway. Stem Cell Res Ther. 2019;10(1):237. doi:10.1186/s13287-019-1301-2
   PubMed Web of Science ®Google Scholar
• Yu HP, Zheng Y, Lu LX, et al. 巨噬细胞游走抑制因子在肝细胞癌组织中的表达及其与ERK1/2信号通路关系的初步研究 [Preliminary study on the expression of MIF in HCC tissues and its relationship with ERK1/2 signaling pathway]. Zhonghua Nei Ke Za Zhi. 2022;61(11):1228–1233. Chinese. doi:10.3760/cma.j.cn112138-20220502-00334
   PubMedGoogle Scholar